Population
Human resting platelets and platelets from patients experiencing coronary artery disease
Comparison
Activation by soluble agonists or von Willebrand… vs Resting state
Design
Preclinical
Key result
Platelet activation induces a shift toward GPVI dimerization, which correlates with P-selectin exposure in patients with coronary artery disease and is limited by P2Y12 antagonists.
Authors
Loading...
GPVI dimerization assessment should not yet alter CAD practice; leaves open its value as reactivity marker or therapeutic target beyond P2Y12 inhibition.
GPVI dimerization is an active process that induces receptor competence and may serve as a new marker to analyze platelet reactivity in coronary artery disease.
Loyau et al. (2011) studied Coronary artery disease. Platelet activation was evaluated on GPVI dimerization and platelet adhesion to collagen. Platelet activation induces a shift toward GPVI dimerization, which correlates with P-selectin exposure in patients with coronary artery disease and is limited by P2Y12 antagonists.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: